Ion Cotarla
Impact in
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Global Cancer Incidence and Screening
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 1
- Cytokine Signaling Pathways and Interactions 1
- Cancer Risks and Factors 1
-
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Ramona Dumitrescu (1 shared paper)Engels Chou (1 shared paper)Alyssa Klein (1 shared paper)Brian S. Seal (1 shared paper)Apar Kishor Ganti (1 shared paper)Priscilla A. Furth (3 shared papers)Shuxun Vincent Ren (2 shared papers)Baljit Singh (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (2 papers)Journal of Cellular and Molecular Medicine (1 paper)BMC Cancer (1 paper)JCO Oncology Practice (1 paper)The Oncologist (1 paper)
- Partner nations
- United States
In The Last Decade
Ion Cotarla
13 papers receiving 1.2k citations
Ion Cotarla's Hit Papers
Peers
Comparison fields: 5 of 63
- Drug Discovery 1
- Oncology 197
- Pulmonary and Respiratory Medicine 281
- Biomaterials 58
- Cancer Research 57
Countries citing papers authored by Ion Cotarla
This map shows the geographic impact of Ion Cotarla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ion Cotarla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ion Cotarla more than expected).
Fields of papers citing papers by Ion Cotarla
This network shows the impact of papers produced by Ion Cotarla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ion Cotarla. The network helps show where Ion Cotarla may publish in the future.
Co-authors
The 25 scholars most cited alongside Ion Cotarla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US Hit paper breakdown → | 2021 | 501 |
| 2 | 2005 | 369 | |
| 3 | 2003 | 123 | |
| 4 | 2012 | 70 | |
| 5 | 2012 | 62 | |
| 6 | 2002 | 25 | |
| 7 | 2008 | 15 | |
| 8 | 2012 | 15 | |
| 9 | 2020 | 15 | |
| 10 | 2007 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 3 |
About Ion Cotarla
Ion Cotarla is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Biomaterials, Immunology and Genetics, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (4 papers), Estrogen and related hormone effects (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Cancer Treatment and Pharmacology (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Immunotherapy and Immune Responses (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper) and Cancer Risks and Factors (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Oncology (197 citations), Pulmonary and Respiratory Medicine (281 citations), Biomaterials (58 citations) and Cancer Research (57 citations). Ion Cotarla has collaborated with scholars based in United States. Frequent co-authors include Ramona Dumitrescu, Engels Chou, Alyssa Klein, Brian S. Seal, Apar Kishor Ganti, Priscilla A. Furth, Shuxun Vincent Ren, Baljit Singh, Ying Zhang and Edmund A. Gehan. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Cellular and Molecular Medicine, BMC Cancer, JCO Oncology Practice and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.